<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">

 Longevity Leaders Conference



SCIENCE OF AGEING | AGE-TECH | LONGEVITY RISK

2nd Annual Conference
21-22 April 2020
133 Houndsditch Liverpool St. London, UK

#longevityleaders
@longevityleader

Created by    LSX Logo

DOWNLOAD BROCHURE

A conference for leaders in longevity science, technology, business and finance

  

'A fantastic collection of the people at the cutting edge of longevity science, technology and business'
Aubrey de Grey, CSO, SENS Research Foundation, & VP, AgeX Therapeutics

Longevity Leaders World Congress

What is it and who is it for?

The Longevity Leaders World Congress is the world’s most influential and powerful global platform designed to connect longevity science leaders, health- tech and age-tech companies and investors, business and consumer innovation leaders, policy makers, health and care providers and financial service industry leaders who all share the mission of extending human health span and delivering on the promise
of healthy ageing.

It is comprised of an exhibition, company showcases, three core conferences, with shared plenaries and networking.

The 3 core pillars of the congress:

  • Science Of Ageing And Age-Related Disease
  • Age-Tech
  • Longevity Risk
Longevity Londers Pillars

Agenda at a glance

21-22 April

09:00


Plenary Keynotes

11:30


The Science Of Ageing Conference


The Longevity Risk Conference


The Age-Tech Conference


Biotech Showcase


Age-Tech Company Showcase

12:30


Interdisciplinary Roundtables

14:15


The Science Of Ageing Conference


The Longevity Risk Conference


The Age-Tech Conference


Biotech Showcase


Age-Tech Company Showcase

16:15


Plenary Keynotes

09:00 - 17:00

Exhibition
&
1-2-1 Partnering

Advisory Board and Key Speakers

The Science Of Ageing And Age-Related Disease

James Peyer, CEO, Apollo Ventures
James Peyer
CEO
Apollo Ventures
Aubrey de Grey, CSO, SENS Research Foundation and VP, AgeX Therapeutics
Aubrey de Grey
CSO, SENS Research Foundation;
VP, AgeX Therapeutics
Michael West, CEO, AgeX Therapeutics
Michael West
CEO
AgeX Therapeutics
Alex Zhavoronkov, CEO, Insilico Medicine
Alex Zhavoronkov
CEO
Insilico Medicine
Tristan Edward, CEO, Life Biosciences
Tristan Edwards
CEO
Life Biosciences
Sree Kant, Head of Business Development, Life Biosciences
Sree Kant
Head of Business Development
Life Biosciences
Joao Pedro de Magalhaes, Scientist and Futurist, University of Liverpool
Joao Pedro de Magalhaes
Scientist and Futurist
University of Liverpool
Mark Allen, CEO, Elevian
Mark Allen
CEO
Elevian

Age-Tech And Risk

John Godfrey, Head of Corporate Affairs, Legal and General
John Godfrey
Head of Corporate Affairs
Legal and General
Wilf Blackburn, CEO, Prudential Singapore
Wilf Blackburn
CEO
Prudential Singapore
Steven Baxter, Head of Longevity Research, Hymans
Steven Baxter
Head of Longevity Research
Hymans
Dominic Endicott, CEO, 4Gen Ventures
Dominic Endicott
CEO
4Gen Ventures
Tina Woods, CEO, Collider Health
Tina Woods
CEO
Collider Health
Paul Gaudin, CEO, CareRooms
Paul Gaudin
CEO
CareRooms
Andrew Fried, Life Sciences Global Industry Leader, IBM
Andrew Fried
Life Sciences Global Industry Leader
IBM
Joe Tighe, Head of Strategy, Benevolent AI
Joe Tighe
Head of Strategy
Benevolent AI

Never Miss An Update

Sign up to event updates to hear about new speakers, promotions, congress news and networking events.